Lung Cancer Treatment at the Markey Cancer Center

A longtime clinical researcher with a wealth of experience in pharmacogenomics, Sherif El-Refai currently works as an oncology pharmacist at the Markey Cancer Center at the University of Kentucky Hospital. In this role, Sherif El-Refai focuses his efforts primarily on lung cancer research, conducted at the Multidisciplinary Lung Cancer Program. A diverse team composed of oncology specialists from a variety of medical fields, the lung and thoracic cancer team provides a multifaceted approach to lung cancer treatment.

In terms of specialties, the lung cancer program at the Markey Cancer Center regularly treats patients with mesothelioma, bronchial carcinoid, esophageal cancer, and small- and non-small-cell lung cancer. The team utilizes some of the latest advances in cancer treatment, from traditional radiation and chemotherapy regiments to the newest and most promising pharmaceuticals. The Lung Cancer Program also participates in clinical trials, which can contribute to the discovery of new cancer treatments.

To learn more about lung and thoracic cancer treatment at the Markey Cancer Center, visit

Published by

Sherif El-Refai

Sherif El-Refai is a recent graduate of the University of Florida’s Hough Graduate School of Business. He received a Masters of Business Administration with a concentration in competitive strategy along with the market and global management. He has experience of working as a pharmacy technician.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s